| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC | 14% | $41,986,839 | 15,666,731 | Redmile Group, LLC | 30 Jun 2025 | |||
| HPWH TH AG | 9.6% | $14,291,858 | 9,788,944 | Dr. Hans-Peter Wild | 15 May 2025 | |||
| Point72 Asset Management, L.P. | 7% | $21,693,047 | 7,831,425 | Point72 Asset Management, L.P. | 16 Jun 2025 | |||
| Prosight Management, LP | 5.8% | $28,781,496 | 7,195,374 | Prosight Management, LP | 30 Sep 2025 | |||
| BlackRock, Inc. | 5% | -4% | $7,173,203 | -$144,108 | 4,913,153 | -2% | BlackRock, Inc. | 31 Mar 2025 |
| Oaktree Capital Group Holdings GP, LLC | 4.1% | $18,693,764 | 4,673,441 | Oaktree Fund Administration, LLC | 30 Sep 2025 | |||
| ORBIMED ADVISORS LLC | 3.6% | $5,019,207 | 3,437,813 | ORBIMED CAPITAL LLC | 31 Dec 2024 |
As of 30 Sep 2025, 105 institutional investors reported holding 68,158,412 shares of ADC Therapeutics SA - Common Shares (ADCT). This represents 55% of the company’s total 124,058,172 outstanding shares.
The largest institutional shareholders of ADC Therapeutics SA - Common Shares (ADCT) together control 51% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Redmile Group, LLC | 13% | 15,666,731 | 0% | 6.1% | $62,666,924 |
| Point72 Asset Management, L.P. | 6.6% | 8,135,651 | +4.8% | 0.07% | $32,542,604 |
| Prosight Management, LP | 6% | 7,472,303 | -29% | 7.2% | $29,889,212 |
| ORBIMED ADVISORS LLC | 4.8% | 5,907,351 | 0% | 0.57% | $23,629,404 |
| BlackRock, Inc. | 3.6% | 4,511,699 | -0.21% | 0% | $18,046,796 |
| MORGAN STANLEY | 3% | 3,669,067 | +20% | 0% | $14,676,268 |
| Nantahala Capital Management, LLC | 1.8% | 2,266,289 | 0% | 0.56% | $9,065,156 |
| GOLDMAN SACHS GROUP INC | 1.3% | 1,594,434 | +3.4% | 0% | $6,377,736 |
| TCG Crossover Management, LLC | 1.1% | 1,390,175 | 0.27% | $5,560,700 | |
| BANK OF AMERICA CORP /DE/ | 1.1% | 1,361,290 | -38% | 0% | $5,445,160 |
| Lynx1 Capital Management LP | 1.1% | 1,325,848 | 1.1% | $5,303,392 | |
| STATE STREET CORP | 1% | 1,295,941 | +5% | 0% | $5,183,764 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.93% | 1,156,721 | -17% | 0.3% | $4,626,884 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.7% | 862,934 | +0.48% | 0% | $3,451,736 |
| CITADEL ADVISORS LLC | 0.66% | 820,715 | +2729% | 0% | $3,282,860 |
| Blue Owl Capital Holdings LP | 0.59% | 733,568 | 0% | 0.91% | $2,934,272 |
| MILLENNIUM MANAGEMENT LLC | 0.57% | 701,619 | +83% | 0% | $2,806,476 |
| BNP PARIBAS FINANCIAL MARKETS | 0.55% | 688,471 | 0% | 0% | $2,753,884 |
| Vantage Consulting Group Inc | 0.55% | 682,998 | 0% | 24% | $2,731,992 |
| Opaleye Management Inc. | 0.55% | 682,529 | 0.39% | $2,730,116 | |
| VANGUARD GROUP INC | 0.48% | 593,954 | +6% | 0% | $2,375,816 |
| PANAGORA ASSET MANAGEMENT INC | 0.44% | 544,261 | +101% | 0.01% | $2,177,044 |
| JANE STREET GROUP, LLC | 0.39% | 487,868 | 0% | $1,951,472 | |
| NORTHERN TRUST CORP | 0.34% | 417,567 | -2.2% | 0% | $1,670,268 |
| JPMORGAN CHASE & CO | 0.27% | 330,597 | +865% | 0% | $1,322,388 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 56,103 | $198,054 | +$100,467 | $3.53 | 5 |
| 2025 Q3 | 68,158,412 | $272,625,712 | -$9,526,921 | $4.00 | 105 |
| 2025 Q2 | 67,952,003 | $182,114,158 | +$35,606,077 | $2.68 | 84 |
| 2025 Q1 | 54,846,167 | $77,332,587 | -$2,528,133 | $1.41 | 82 |
| 2024 Q4 | 56,494,277 | $112,422,732 | -$3,041,138 | $1.99 | 82 |
| 2024 Q3 | 54,883,537 | $172,881,709 | +$3,394,419 | $3.15 | 76 |
| 2024 Q2 | 51,801,951 | $163,693,841 | +$51,364,315 | $3.16 | 73 |
| 2024 Q1 | 34,683,534 | $155,728,721 | +$7,168,355 | $4.49 | 36 |
| 2023 Q4 | 33,953,461 | $56,361,695 | -$3,915,509 | $1.66 | 36 |
| 2023 Q3 | 39,458,503 | $35,390,528 | -$10,272,333 | $0.90 | 40 |
| 2023 Q2 | 45,357,348 | $97,515,460 | -$1,939,928 | $2.15 | 55 |
| 2023 Q1 | 46,611,135 | $90,890,151 | +$6,156,453 | $1.95 | 57 |
| 2022 Q4 | 38,834,584 | $149,117,927 | +$3,712,534 | $3.84 | 59 |
| 2022 Q3 | 36,621,247 | $176,523,672 | +$9,038,590 | $4.82 | 60 |
| 2022 Q2 | 34,475,113 | $274,062,429 | +$4,571,679 | $7.95 | 52 |
| 2022 Q1 | 34,123,674 | $501,279,862 | +$2,970,760 | $14.69 | 44 |
| 2021 Q4 | 33,799,357 | $682,750,000 | +$19,180,842 | $20.20 | 50 |
| 2021 Q3 | 32,792,604 | $890,647,136 | -$45,594,727 | $27.16 | 51 |
| 2021 Q2 | 33,533,099 | $816,251,800 | +$17,173,667 | $24.35 | 53 |
| 2021 Q1 | 32,826,058 | $801,283,858 | +$19,636,706 | $24.41 | 55 |
| 2020 Q4 | 32,141,073 | $1,028,835,000 | +$31,200,598 | $32.01 | 51 |
| 2020 Q3 | 28,226,306 | $921,776,783 | +$216,837,760 | $32.99 | 51 |
| 2020 Q2 | 21,557,623 | $1,000,339,109 | +$1,000,339,111 | $46.81 | 41 |